Patients with lung cancer who received an immune checkpoint inhibitor before surgery had improved long-term survival rates and lower rates of recurrence than historically observed, according to a study published in an AACR journal....
Pembrolizumab was approved to treat some patients with lung cancer after surgery and chemotherapy. The U.S. Food and Drug Administration (FDA) has approved pembrolizumab (Keytruda) for the adjuvant treatment of stage IB, II, or...
A second inhibitor of the difficult-to-target KRAS protein was approved to treat certain lung cancers. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to adagrasib (Krazati) for adult patients with locally...
A magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
The FDA granted accelerated approval to the first HER2-targeted therapy for the treatment of non-small cell lung cancer with activating HER2 mutations The U.S. Food and Drug Administration (FDA) has granted accelerated approval to...
Screenings, treatment advances and declines in smoking have led to a decrease in lung cancer death rates.
Three out of four people with advanced colorectal cancer suffer significant financial hardship, and lung cancer patients who quit smoking experience increased survival.
FDA approves drug to prevent graft versus host disease and decline in lung cancer deaths linked to screening.
THE FDA APPROVED THE FIRST ADJUVANT IMMUNOTHERAPY FOR EARLY LUNG CANCER The U.S. Food and Drug Administration (FDA) granted expanded approval to atezolizumab (Tecentriq) to include the treatment of certain patients with early non-small...
Treatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now